Project-specific; negotiated funding and cost-sharing requirements
To accelerate the development of innovative products capable of preventing, diagnosing or treating drug-resistant bacterial infections.
You will be taken to the funder's own website. Applications, guidelines and final eligibility decisions are managed by the funder, not by IVAN Research Institute.